Biesterfeld Stefan, Josef Juliana
Institute of Pathology, Technical University of Aachen, Pauwelsstr. 30, 52074 Aachen, Federal Republic of Germany.
Anticancer Res. 2002 Sep-Oct;22(5):3019-23.
For the analysis of cellular proliferative activity, the MIB-1 immunopositivity of keratoacanthoma (KA, n = 49), squamous cell carcinoma (SCC, n-48) and each of four cases diagnosed probably as KA or probably as SCC were analyzed by means of immunohistometry.
Immunohistochemical reactions were performed on 3-micron sections from routinely formalin-fixed and paraffin-embedded surgical specimens, using an indirect peroxidase method. The rate of immunostained cells was determined using a TV-image analysis system CM-2 (Hund, Germany). Twenty viewing fields (0.97 mm2) were measured with 20:1 objective magnification. An average of 1688 cells were assessed in each case.
The mean MIB-1 immunopositivity (MIB-1mean) was higher in SCC (42.3% +/- 19.1%) than in KA (26.8% +/- 9.8%). The distribution of the single values differed significantly (p = 0.0002). To test the suitability of MIB-1 immunohistometry for the differential diagnosis between KA and SCC, various thresholds were investigated. Using a threshold of 30%, SCC can be detected with a sensitivity of 70.8% (34 out of 48) and a specificity of 67.3% (33 out of 49). If a specificity of > or = 85% is required (42 out of 49, 85.7%), the sensitivity of the test decreases to 56.3% (27 out of 48) based on a threshold of 37.5%. Using the MIB-1 value of the most positive focus of the lesion (MIB-1max), the results were of minor significance; at a specificity level of > or = 85% (42 out of 49, 85.7%) a sensitivity rate of only 43.8% (21 out of 48) could be obtained (threshold: 75%).
As some overlap of the single values has to be considered, MIB-1 immunohistometry, although presenting new insights into the proliferative potential of KA and SCC, is of only limited value for the differential diagnosis of the two lesions in routine surgical pathology.
为分析细胞增殖活性,采用免疫组织化学计量法对49例角化棘皮瘤(KA)、48例鳞状细胞癌(SCC)以及4例可能诊断为KA或可能诊断为SCC的病例的MIB-1免疫阳性情况进行分析。
采用间接过氧化物酶法,对常规福尔马林固定、石蜡包埋手术标本的3微米切片进行免疫组织化学反应。使用CM-2电视图像分析系统(德国洪德公司)测定免疫染色细胞的比例。在20:1物镜放大倍数下测量20个视野(0.97平方毫米)。每例平均评估1688个细胞。
SCC的平均MIB-1免疫阳性率(MIB-1mean)(42.3%±19.1%)高于KA(26.8%±9.8%)。单个值的分布差异显著(p = 0.0002)。为检验MIB-1免疫组织化学计量法对KA和SCC进行鉴别诊断的适用性,研究了不同阈值。使用30%的阈值,检测SCC的灵敏度为70.8%(48例中的34例),特异性为67.3%(49例中的33例)。如果要求特异性≥85%(49例中的42例,85.7%),基于37.5%的阈值,检测的灵敏度降至56.3%(48例中的27例)。使用病变最阳性灶的MIB-1值(MIB-1max),结果意义不大;在特异性水平≥85%(49例中的42例,85.7%)时,灵敏度仅为43.8%(48例中的21例)(阈值:75%)。
由于必须考虑单个值存在一定重叠,MIB-1免疫组织化学计量法虽然为KA和SCC的增殖潜能提供了新见解,但在常规手术病理学中对这两种病变进行鉴别诊断的价值有限。